If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Taro Oba is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Smoking Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Thymoma Medicine & Life Sciences
Mutation Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

  • 660 Citations
  • 14 h-Index
  • 33 Article
  • 1 Comment/debate

Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma

Kinoshita, F., Takada, K., Yamada, Y., Oku, Y., Kosai, K., Ono, Y., Tanaka, K., Wakasu, S., Oba, T., Osoegawa, A., Tagawa, T., Shimokawa, M., Oda, Y. & Mori, M., Jan 1 2019, (Accepted/In press) In : Annals of Surgical Oncology.

Research output: Contribution to journalArticle

Forkhead Transcription Factors
Tumor-Infiltrating Lymphocytes
Disease-Free Survival
Lymphocytes
Cell Death

Short progression-free survival of ALK inhibitors sensitive to secondary mutations in ALK-positive NSCLC patients

Haratake, N., Seto, T., Takamori, S., Toyozawa, R., Nosaki, K., Miura, N., Ohba, T., Toyokawa, G., Taguchi, K., Yamaguchi, M., Shimokawa, M. & Takenoyama, M., Sep 1 2019, In : Thoracic Cancer. 10, 9, p. 1779-1787 9 p.

Research output: Contribution to journalArticle

Open Access
Non-Small Cell Lung Carcinoma
Disease-Free Survival
Protein-Tyrosine Kinases
Mutation
Therapeutics

The Influence of Clinical T Factor on Predicting Pathologic N Factor in Resected Lung Cancer

Shimamatsu, S., Takenoyama, M., Shimokawa, M., Takada, K., Edagawa, M., Toyozawa, R., Nosaki, K., Oba, T., Tagawa, T., Yamaguchi, M., Taguchi, K. & Seto, T., Oct 2019, In : Annals of Thoracic Surgery. 108, 4, p. 1080-1086 7 p.

Research output: Contribution to journalArticle

Glass
Lung Neoplasms
Neoplasms
Neoplasm Staging
Non-Small Cell Lung Carcinoma
9 Citations (Scopus)

Serum MicroRNA-150 Predicts Prognosis for Early-Stage Non-Small Cell Lung Cancer and Promotes Tumor Cell Proliferation by Targeting Tumor Suppressor Gene SRCIN1

Zhang, L., Lin, J., Ye, Y., Oba, T., Gentile, E., Lian, J., Wang, J., Zhao, Y., Gu, J., Wistuba, I. I., Roth, J. A., Ji, L. & Wu, X., Jun 2018, In : Clinical Pharmacology and Therapeutics. 103, 6, p. 1061-1073 13 p.

Research output: Contribution to journalArticle

Tumor Suppressor Genes
MicroRNAs
Non-Small Cell Lung Carcinoma
Cell Proliferation
Serum
4 Citations (Scopus)

Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics

Gentile, E., Oba, T., Lin, J., Shao, R., Meng, F., Cao, X., Lin, H. Y., Mourad, M., Pataer, A., Baladandayuthapani, V., Cai, D., Roth, J. A. & Ji, L., Jan 1 2017, In : Oncotarget. 8, 29, p. 48222-48239 18 p.

Research output: Contribution to journalArticle

Open Access
RNA Interference
Nanoparticles
MicroRNAs
Small Interfering RNA
Lung Neoplasms